Screening for occult cancer in idiopathic venous thromboembolism — Systemic review and meta-analysis
- 11 May 2017
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 42, 74-80
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Epidemiology of cancer-associated venous thrombosisBlood, 2013
- Screening for occult malignancy with FDG‐PET/CT in patients with unprovoked venous thromboembolismInternational Journal of Cancer, 2013
- Is extensive screening for cancer in idiopathic venous thromboembolism warranted?Journal of Thrombosis and Haemostasis, 2010
- Venous thromboembolic events and organ‐specific occult cancers: a review and meta‐analysisJournal of Thrombosis and Haemostasis, 2008
- Venous thromboembolism (VTE) in EuropeThrombosis and Haemostasis, 2007
- Venous thromboembolismBMJ, 2006
- Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolismJournal of Thrombosis and Haemostasis, 2004
- Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trialJournal of Thrombosis and Haemostasis, 2004
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with CancerNew England Journal of Medicine, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986